Cerebral Vascular Reactivity Measurement Using Sequential Hypoxia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring cerebrovascular reactivity using hypoxia as a vasoactive stimulus suffer from variability due to unintended CO2 changes and limited spatial and temporal resolution, particularly in capillary blood flow measurements.
Innovation Solution
A method involving sequential gas delivery to induce controlled hypoxic and reoxygenation conditions, with independent CO2 control, combined with multi-echo T2* imaging to measure cerebral blood flow directly, allowing for precise determination of capillary blood flow and perfusion metrics.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If hypercapnia is produced by inhaled or endogenously accumulated carbon dioxide to measure cerebrovascular reactivity, then the blood-flow change can be measured, but the measurement is difficult to reproduce precisely between and within subjects
Solution Approach 1:
The patent changes the physiological parameter used as vasoactive stimulus from CO2 (hypercapnia) to oxygen (hypoxia). By controlling arterial oxygen saturation levels, the method achieves a more reliable and repeatable cerebrovascular reactivity measurement, as oxygen levels can be precisely controlled through gas delivery systems without the variability inherent in CO2 accumulation methods.
2Measurement precision
If BOLD imaging is used to infer blood-flow change, then the measurement can be obtained, but the accuracy is constrained by reliance on stable cerebral oxygen consumption and blood volume
Solution Approach 1:
The patent extracts the measurement from indirect BOLD signal inference and obtains direct blood-flow measurement through arterial spin labeling. This extraction eliminates the confounding factors of stable cerebral oxygen consumption and blood volume assumptions, providing more accurate blood-flow change measurements during hypoxic stimulation.
3Quantity of substance
If phase contrast MRI is used to measure cerebral blood flow, then the measurement can be obtained, but only large vessels or heart valves can be measured, so no measurements are taken of capillary blood flow
Solution Approach 1:
The patent replaces the mechanical phase contrast MRI method with a different measurement approach (arterial spin labeling) that is not constrained by vessel size. This substitution enables measurement of blood flow in capillaries and small vessels, significantly expanding the spatial coverage from only large vessels to the entire cerebral vasculature including the capillary bed.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides a repeatable and accurate assessment of cerebral vascular reactivity by minimizing variability and enabling direct measurement of capillary blood flow, improving the precision and reliability of cerebrovascular-reactivity mapping.
Implementation Method 1
employing sequential gas delivery to impose controlled reductions in arterial oxygen saturation, followed by abrupt reoxygenation
Implementation Method 2
The cerebral blood flow is directly measured from multi-echo T2* imaging during the reoxygenation events
Data Source
AI summary
A method for quantitative measurement of cerebral vascular reactivity (CVR) combines sequential gas delivery with ΔR2*-based perfusion analysis. Sequential gas delivery imposes a first stepwise reoxygenation after a first hypoxic condition and a second stepwise reoxygenation after a second hypoxic condition. In one mode, the second hypoxic condition produces greater vasodilation than the first; in another mode both hypoxia levels are minimal and an independent vasoactive stimulus, such as hypercapnia or acetazolamide, is applied between reoxygenations. MRI gradient-echo imaging records the ΔR2* time course in a target voxel during each reoxygenation. Sigmoid fitting yields perfusion metrics including relative cerebral blood flow, relative cerebral blood volume and mean transit time. Comparison of the metrics derived from the two reoxygenations provides a numerical CVR value that can be reproduced across sessions and subjects.